Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. Stream Los Angeles News ...

Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. CEO Pascal Soriot is ...

AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that ...

AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest Frederick.

Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 10 best defensive stocks to buy in a volatile market. On July 4, the company entered into a multi-year agreement with Modella AI.

The boss of Astrazeneca has reportedly voiced his desire to transfer the pharma giant's listing to the US, in what would be a major blow to London.

AstraZeneca has announced a new clinical study titled ‘Pregnancy and Infant Outcomes in Anifrolumab Exposed Pregnancies Using PRegnancy Outcomes Intensive Monitoring (PRIM) Data: The Anifrolumab ...

AstraZeneca and Rossari Biotech posted their highest revenue in 13 quarters, with Rossari also seeing increased institutional interest.